Laura B Zahodne1, Michael Marsiske, Dawn Bowers. 1. Cognitive Neuroscience Division, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Abstract
OBJECTIVE: Psychological symptoms are common in Parkinson's disease (PD). Psychological symptoms do not respond to psychotropic medications as well in patients with PD as in patients with psychiatric illnesses who do not have PD. Evidence that PD patients can be classified into distinct psychological symptom subgroups is conflicting. This study sought to examine potential psychological heterogeneity in PD with a broader range of instruments than has been used in previous studies. METHODS: A comprehensive battery of psychological measures assessing dysphoria, apathy, anhedonia, anxiety, and negative affect was administered to 95 PD patients without global cognitive impairment. Latent class analysis was used to identify subgroups of patients based on continuous variables derived from the psychological battery. Multinomial regression was used to examine predictors of classification. RESULTS: The latent class analysis identified three subgroups with incremental levels of psychopathology across most symptom domains. One exception was a greater level of affective flattening in the "psychologically healthy" group compared with the "moderate symptoms" group. Greater motor dysfunction and less education were associated with greater severity of psychological symptoms. CONCLUSIONS: These results support high psychological co-morbidity in PD, which complicates the treatment of individual symptoms. In addition, emotional blunting and anhedonia may be less indicative of widespread psychological distress than anxiety, dysphoria, and cognitive aspects of apathy. Clinicians should be aware that PD patients with greater motor dysfunction and less education are at greater risk not only for depression but also for a variety of other psychological symptoms that may not be routinely assessed.
OBJECTIVE: Psychological symptoms are common in Parkinson's disease (PD). Psychological symptoms do not respond to psychotropic medications as well in patients with PDas in patients with psychiatric illnesses who do not have PD. Evidence that PDpatients can be classified into distinct psychological symptom subgroups is conflicting. This study sought to examine potential psychological heterogeneity in PD with a broader range of instruments than has been used in previous studies. METHODS: A comprehensive battery of psychological measures assessing dysphoria, apathy, anhedonia, anxiety, and negative affect was administered to 95 PDpatients without global cognitive impairment. Latent class analysis was used to identify subgroups of patients based on continuous variables derived from the psychological battery. Multinomial regression was used to examine predictors of classification. RESULTS: The latent class analysis identified three subgroups with incremental levels of psychopathology across most symptom domains. One exception was a greater level of affective flattening in the "psychologically healthy" group compared with the "moderate symptoms" group. Greater motor dysfunction and less education were associated with greater severity of psychological symptoms. CONCLUSIONS: These results support high psychological co-morbidity in PD, which complicates the treatment of individual symptoms. In addition, emotional blunting and anhedonia may be less indicative of widespread psychological distress than anxiety, dysphoria, and cognitive aspects of apathy. Clinicians should be aware that PDpatients with greater motor dysfunction and less education are at greater risk not only for depression but also for a variety of other psychological symptoms that may not be routinely assessed.
Authors: Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh Journal: Mov Disord Date: 2009-07-15 Impact factor: 10.338
Authors: Nadeeka N W Dissanayaka; Anna Sellbach; Peter A Silburn; John D O'Sullivan; Rodney Marsh; George D Mellick Journal: J Affect Disord Date: 2011-02-26 Impact factor: 4.839
Authors: Sergio Starkstein; Milan Dragovic; Ricardo Jorge; Simone Brockman; Marcelo Merello; Robert G Robinson; David Bruce; Mark Wilson Journal: Mov Disord Date: 2011-07-07 Impact factor: 10.338
Authors: Richard G Brown; Sabine Landau; John V Hindle; Jeremy Playfer; Michael Samuel; Kenneth C Wilson; Catherine S Hurt; Rachel J Anderson; Joanna Carnell; Lucy Dickinson; Grant Gibson; Rachel van Schaick; Katie Sellwood; Bonnita A Thomas; David J Burn Journal: J Neurol Neurosurg Psychiatry Date: 2011-01-08 Impact factor: 10.154
Authors: Klaus Seppi; Daniel Weintraub; Miguel Coelho; Santiago Perez-Lloret; Susan H Fox; Regina Katzenschlager; Eva-Maria Hametner; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio Journal: Mov Disord Date: 2011-10 Impact factor: 10.338
Authors: D Aarsland; K Brønnick; G Alves; O B Tysnes; K F Pedersen; U Ehrt; J P Larsen Journal: J Neurol Neurosurg Psychiatry Date: 2009-08 Impact factor: 10.154
Authors: Albert F G Leentjens; Kathy Dujardin; Laura Marsh; Pablo Martinez-Martin; Irene H Richard; Sergio E Starkstein; Daniel Weintraub; Cristina Sampaio; Werner Poewe; Oliver Rascol; Glenn T Stebbins; Christopher G Goetz Journal: Mov Disord Date: 2008-10-30 Impact factor: 10.338
Authors: Maurizio Fava; A John Rush; Jonathan E Alpert; G K Balasubramani; Stephen R Wisniewski; Cheryl N Carmin; Melanie M Biggs; Sidney Zisook; Andrew Leuchter; Robert Howland; Diane Warden; Madhukar H Trivedi Journal: Am J Psychiatry Date: 2008-01-02 Impact factor: 18.112
Authors: Shahrzad Mavandadi; Sarra Nazem; Thomas R Ten Have; Andrew D Siderowf; John E Duda; Matthew B Stern; Daniel Weintraub Journal: Am J Geriatr Psychiatry Date: 2009-11 Impact factor: 4.105
Authors: Laura Brennan; Kathryn M Devlin; Sharon X Xie; Dawn Mechanic-Hamilton; Baochan Tran; Howard H Hurtig; Alice Chen-Plotkin; Lama M Chahine; James F Morley; John E Duda; David R Roalf; Nabila Dahodwala; Jacqueline Rick; John Q Trojanowski; Paul J Moberg; Daniel Weintraub Journal: J Parkinsons Dis Date: 2017 Impact factor: 5.568